🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of oral ma...
Status
Unknown
Location
Centre Hospitalier Universitaire d'Amiens
Start Date
2020-07-01
Trial ID
NCT04333108
Treatments Being Tested
The objective is to assess the efficacy and safety of masitinib at 7.5 mg/k...
Status
Terminated
Location
Blumenthal Cancer Centre
Start Date
2011-01
Trial ID
NCT01280565
Treatments Being Tested
This is a 12 weeks study aimed at assessing the safety and efficacy of 2 do...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00831974
Treatments Being Tested
To evaluate the efficacy and safety of two dosing schemes of oral masitinib...
Status
Unknown
Location
St Charles Clinical Research
Start Date
2022-07-01
Trial ID
NCT05449444
Treatments Being Tested
Study objective is to evaluate the efficacy of the combination of masitinib...
Status
Unknown
Location
Centre Hospitalier du Pays d'Aix
Start Date
2020-06-01
Trial ID
NCT04622865
Treatments Being Tested
The objective is to compare the efficacy and safety of masitinib at 12 mg/k...
Status
Completed
Location
Washington University School of Medicine
Start Date
2012-04
Trial ID
NCT01694277
A double-blind, placebo-controlled, randomized, parallel-group study to eva...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT01045577
The objective is to evaluate the efficacy and safety of masitinib in combin...
Status
Completed
Location
Centre hospitalo-universitaire de Beni Messous
Start Date
2014-04
Trial ID
NCT02490488
Treatments Being Tested
To assess the mass balance recovery after a single oral dose of 14C-AB1010...
Status
Completed
Location
Quotient Sciences
Start Date
2017-07-31
Trial ID
NCT05200169
Treatments Being Tested
This phase 2 study was designed to evaluate the activity of oral masitinib ...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00976118
Treatments Being Tested